Rofact · DIN 00343617 · 300 mg · capsule
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Rofact · DIN 00343617
Manufacturer: Valeant Canada Ltd.; listing date 1996-10-01
Health Canada: Marketed since 2019-07-02 · brand ROFACT · ATC J04AB02 RIFAMPICIN · form Capsule · route Oral · ingredients RIFAMPIN 300 MG · company Bausch health, canada inc. · schedule Prescription
Rofact: Formulary list price $1.45 per unit (the source does not state the unit; exact figure $1.4452). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00343617)
Source record
DIN 00343617: Rofact
Raw flags: sec3=Y
Item: 081600008; group id 58; item number 0117; lccId None; manufacturer id VAL
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $1.4452; ministry $1.4452
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00343617
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2863
Shortage status: not checked (no credentials)